Form 4 for AXGN Axogen, Inc.
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0000805928-25-000034 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-05 | 2025-03-03 | AXGN | Wendell Amy McBride | Dir | S - Sale | $20.02 | -5,000 | 97.9K | -5% | -$100.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-03 | S | D | 5,000 | $20.02 | 97,899 | D | — | — | (F1) The reported shares were sold pursuant to an Approved Rule 10b5-1 Plan, as defined under the Company's Insider Trading Policy. (F2) The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $19.91 to $20.15 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |